BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 32744982)

  • 1. Recent Nanocarrier Approaches for Targeted Drug Delivery in Cancer Therapy.
    Bhatia R; Sharma A; Narang RK; Rawal RK
    Curr Mol Pharmacol; 2021; 14(3):350-366. PubMed ID: 32744982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in Delivery of Chemotherapeutic Agents for Cancer Treatment.
    Yadav A; Singh S; Sohi H; Dang S
    AAPS PharmSciTech; 2021 Dec; 23(1):25. PubMed ID: 34907501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential of Nanocarrier-Based Drug Delivery Systems for Brain Targeting: A Current Review of Literature.
    Alotaibi BS; Buabeid M; Ibrahim NA; Kharaba ZJ; Ijaz M; Noreen S; Murtaza G
    Int J Nanomedicine; 2021; 16():7517-7533. PubMed ID: 34795481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzyme-responsive smart nanocarriers for targeted chemotherapy: an overview.
    Kapalatiya H; Madav Y; Tambe VS; Wairkar S
    Drug Deliv Transl Res; 2022 Jun; 12(6):1293-1305. PubMed ID: 34251612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smart nanocarrier-based drug delivery systems for cancer therapy and toxicity studies: A review.
    Hossen S; Hossain MK; Basher MK; Mia MNH; Rahman MT; Uddin MJ
    J Adv Res; 2019 Jan; 15():1-18. PubMed ID: 30581608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smart Nanocarriers as an Emerging Platform for Cancer Therapy: A Review.
    Kenchegowda M; Rahamathulla M; Hani U; Begum MY; Guruswamy S; Osmani RAM; Gowrav MP; Alshehri S; Ghoneim MM; Alshlowi A; Gowda DV
    Molecules; 2021 Dec; 27(1):. PubMed ID: 35011376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanocarriers-Mediated Drug Delivery Systems for Anticancer Agents: An Overview and Perspectives.
    Edis Z; Wang J; Waqas MK; Ijaz M; Ijaz M
    Int J Nanomedicine; 2021; 16():1313-1330. PubMed ID: 33628022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smart nanoparticles for cancer therapy.
    Sun L; Liu H; Ye Y; Lei Y; Islam R; Tan S; Tong R; Miao YB; Cai L
    Signal Transduct Target Ther; 2023 Nov; 8(1):418. PubMed ID: 37919282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyaluronic acid-modified mesoporous silica-coated superparamagnetic Fe
    Fang Z; Li X; Xu Z; Du F; Wang W; Shi R; Gao D
    Int J Nanomedicine; 2019; 14():5785-5797. PubMed ID: 31440047
    [No Abstract]   [Full Text] [Related]  

  • 11. Mesoporous Silica Nanoparticles as a Prospective and Promising Approach for Drug Delivery and Biomedical Applications.
    Pu X; Li J; Qiao P; Li M; Wang H; Zong L; Yuan Q; Duan S
    Curr Cancer Drug Targets; 2019; 19(4):285-295. PubMed ID: 30520373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast Cancer Targeted Treatment Strategies: Promising Nanocarrier Approaches.
    Malliappan SP; Kandasamy P; Chidambaram S; Venkatasubbu D; Perumal SK; Sugumaran A
    Anticancer Agents Med Chem; 2020; 20(11):1300-1310. PubMed ID: 31642415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanocarriers for anticancer drugs--new trends in nanomedicine.
    Drbohlavova J; Chomoucka J; Adam V; Ryvolova M; Eckschlager T; Hubalek J; Kizek R
    Curr Drug Metab; 2013 Jun; 14(5):547-64. PubMed ID: 23687925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of major parameters of nanoparticles on their physical and chemical properties and recent application of nanodrug delivery system in targeted chemotherapy.
    Zhang J; Tang H; Liu Z; Chen B
    Int J Nanomedicine; 2017; 12():8483-8493. PubMed ID: 29238188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Review on Recent Technologies and Patents on Silica Nanoparticles for Cancer Treatment and Diagnosis.
    Gupta A; Kushwaha SS; Mishra A
    Recent Pat Drug Deliv Formul; 2020; 14(2):126-144. PubMed ID: 32928094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanocarrier-based Drug Delivery System for Cancer Therapeutics: A Review of the Last Decade.
    Sohail M; Guo W; Li Z; Xu H; Zhao F; Chen D; Fu F
    Curr Med Chem; 2021; 28(19):3753-3772. PubMed ID: 33019919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanocarriers for cancer-targeted drug delivery.
    Kumari P; Ghosh B; Biswas S
    J Drug Target; 2016; 24(3):179-91. PubMed ID: 26061298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances and prospects in gemcitabine drug delivery systems.
    Paroha S; Verma J; Dubey RD; Dewangan RP; Molugulu N; Bapat RA; Sahoo PK; Kesharwani P
    Int J Pharm; 2021 Jan; 592():120043. PubMed ID: 33152476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring Therapeutic Potential of Nanocarrier Systems Against Breast Cancer.
    Kumar L; Baldi A; Verma S; Utreja P
    Pharm Nanotechnol; 2018; 6(2):94-110. PubMed ID: 29866028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Applications of Nanoparticles for Anticancer Drug Delivery: A Review.
    Zhu Y; Liao L
    J Nanosci Nanotechnol; 2015 Jul; 15(7):4753-73. PubMed ID: 26373036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.